Jun 20
|
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
|
May 29
|
Bausch + Lomb’s enVista Envy IOL obtains Health Canada approval
|
Dec 22
|
Bausch Health (BHC) Ulcerative Colitis Drug Meets Primary Goal
|
Dec 21
|
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
|
Dec 18
|
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
|
Dec 18
|
DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
|
Dec 5
|
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
|
Dec 1
|
Humana (HUM) Extends CINQCARE's Home Care Model to MA Members
|
Nov 30
|
Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?
|
Nov 29
|
5 Canadian stocks that have been complete disasters — and what investors can learn from them
|
Aug 9
|
3 Top-Ranked Value Stocks to Buy as Recession Worries Loom
|
Aug 8
|
Best Momentum Stock to Buy for August 8th
|
Aug 8
|
Best Value Stocks to Buy for August 8th
|
Aug 8
|
New Strong Buy Stocks for August 8th
|
Aug 5
|
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2023 Earnings Call Transcript
|
Aug 5
|
Bausch Health Companies Inc. (NYSE:BHC) Q2 2023 Earnings Call Transcript
|
Jul 13
|
Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
|